Subscribe to Journal
Get full journal access for 1 year
only $20.17 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Schaefer, K.A. et al. Nat. Methods 14, 547–548 (2017).
Pattanayak, V. et al. Nat. Biotechnol. 31, 839–843 (2013).
Veres, A. et al. Cell Stem Cell 15, 27–30 (2014).
Kim, D. et al. Nat. Methods 12, 237–243 (2015).
Iyer, V. et al. Nat. Methods 12, 479 (2015).
Tsai, S.Q. et al. Nat. Biotechnol. 33, 187–197 (2015).
Schaefer, K.A. et al. Preprint at https://www.biorxiv.org/content/early/2017/06/23/154450 (2017).
van Overbeek, M. et al. Mol. Cell 63, 633–646 (2016).
This work was supported by the National Science Foundation (DGE1144152 to C.A.L.), National Institutes of Health (R35 GM118158 to J.K.J. and R00 HG008399 to L.P.), the Defense Advanced Research Projects Agency (HR0011-17-2-0042 to J.K.J. and L.P.), and the Desmond and Ann Heathwood Massachusetts General Hospital Research Scholar Award (J.K.J.). We thank B. Kleinstiver, J. Lopez, and A. Anthony for helpful discussions.
J.K.J. has financial interests in Beam Therapeutics, Editas Medicine, Monitor Biotechnologies, Pairwise Plants, Poseida Therapeutics, and Transposagen Biopharmaceuticals. M.J.A. has financial interests in Monitor Biotechnologies. J.K.J.'s and M.J.A.'s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies.
Integrated supplementary information
Variants were called using the intersection of three somatic cancer mutation calling software frameworks for each mouse using FVB as a “normal” tissue. We were able to reproduce 91.1% and 93.5% of the previously reported variants (green; left) though our analysis framework differed slightly as we employed GATK best practices. The number of mutations called and concordant with the previously reported variants was similar for an identical iteration of the pipeline run on downsampled data for the F03 and F05 mice (right), indicating that the differential coverage reported by the authors did not have a substantial impact on the analysis.
Panel E shows the computed genetic distance between the three mice under each of the two models (Panels A, C) and observed variants (Panels B, D).
Supplementary Figure 3 Distance distributions of Schaefer et al.-reported SNVs to closest Cas-OFFinder predictions.
Log10 minimum distances were plotted for all Schaefer et al.-reported SNVs to the closest Cas-OFFinder in-silico off-target prediction (mismatch up to 6bp, DNA/RNA bulges up to 2bp). Three independent randomly sampled common dbSNPs were also plotted to assess the background of the analysis.
Supplementary Figure 4 Motif enrichment at variants identified through the Schaefer et al. pipeline.
Motif sequences were inferred using HOMER. Motifs were inferred using sequences of 100bp centered at the SNPs obtained with the pipeline proposed by Schaefer et al. (mm10 reference genome) for the groups F03 vs FVB and F05 vs FVB as target sets. No enriched motifs were present for both SNP sets, leaving no clear mechanism for potential shared DNA sequence recognition by Cas9.
We sought to quantify the empirical probability that 118 indels shared between F03 and F05 mice would all be the same length (left). From empirical indel distributions described in van Overbeek et al., we simulated paired indel occurrences (right) to highlight the heterogeneity of the indel outcome process. With the least heterogeneous indel size distribution, we use the binomial test to assess the significance of observing 118 paired indel size matches (p = 1.5 e-42).
Heatmaps showing the overlap of the nucleotide observed at a SNV in F03, and the nucleotide observed in F05 at the same location. In each heatmap, only SNVs that are homozygous reference, and then show a variant in both F03 and F05 are shown. Notably, the density along the diagonal shows that a vast majority (> 99%) of variant loci shared in F03 and F05 also share the same nucleotide base.
Left: Pie chart showing the fraction of dbSNP variants called by the GATK pipeline that have the same genotype in F03 and F05 (but not in FVB). Right: Variants called by the Schaefer et al. pipeline were mapped to the closest dbSNP variant. This pie chart shows the fraction of these dbSNP variants that had the same genotype in F03 and F05. The variants that are closest to calls from the Schaefer et al. pipeline are significantly enriched for variants whose genotype is shared between F03 and F05.
About this article
Cite this article
Lareau, C., Clement, K., Hsu, J. et al. Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo”. Nat Methods 15, 238–239 (2018). https://doi.org/10.1038/nmeth.4541
Communications Biology (2020)
Vascular Pharmacology (2019)
Nature Reviews Clinical Oncology (2019)
Optimizing CRISPR/Cas9 technology for precise correction of the Fgfr3-G374R mutation in achondroplasia in mice
Journal of Biological Chemistry (2019)
Nature Communications (2019)